Doximity operates a digital platform for healthcare professionals, providing tools for communication, collaboration, and career development. Its core products include a professional network for physicians, telehealth services, and medical content. Major business segments encompass subscription services for healthcare organizations and advertising revenue from pharmaceutical companies. The primary revenue sources are membership fees and advertising.
The investment profile of Doximity is more aligned with balanced investors, given its focus on both growth potential and the current market challenges. The stock exhibits moderate volatility and has shown a decline in revenue, indicating a cautious outlook. Investors may find it suitable for a medium-term horizon, with considerations for liquidity and experience levels.
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-06-03 02:39 | Hold | Sell | Weak fundamentals and negative momentum raise significant concerns. |
| 2026-05-08 15:03 | — | Hold | Positive revenue growth, but high volatility and risk. |
| 2026-05-08 05:23 | Sell | Hold | Компания Doximity показывает положительную динамику в краткосрочной перспективе, однако значительное падение за последние 120 дней и высокий риск делают её менее привлекательной для покупки в данный момент. |
| Date | Analyst | Action | Target | Price Then |
|---|---|---|---|---|
| 2026-05-14 20:45 | Barclays | Rating Downgraded | — → 20 | 18.01 |
| 2026-05-14 13:21 | Truist Financial | Target Lowered | 29 → 19 | 17.87 |
| 2026-05-14 11:42 | BMO Capital | Target Lowered | 25 → 20 | 23.39 |
